Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... [Yahoo! Finance]
Ironwood Pharmaceuticals, Inc. - Class A (IRWD)
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.ironwoodpharma.com
Company Research
Source: Yahoo! Finance
Operating Cash Flow: $10 million generated in Q3 2024. Adjusted EBITDA: $26 million in Q3 2024. Ironwood Revenue: $92 million in Q3 2024, a decrease of 19% year-over-year. GAAP Net Income: $4 million in Q3 2024. Cash and Cash Equivalents: $88 million at the end of Q3 2024. Full Year 2024 Guidance: LINZESS U.S. net sales expected between $900 million and $950 million; Ironwood revenue between $350 million and $375 million; adjusted EBITDA greater than $75 million. Warning! GuruFocus has detected 7 Warning Signs with IRWD. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript LINZESS continues to show robust year-over-year prescription demand growth, with a 13% increase in the third quarter. Ironwood Pharmaceuticals Inc ( NASDAQ:IRWD ) is on track to submit an NDA for apraglutide in the first quarter of 2025, targeting a significant unmet need in short bowel syndrome. The company present
Show less
Read more
Impact Snapshot
Event Time:
IRWD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRWD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRWD alerts
High impacting Ironwood Pharmaceuticals, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
IRWD
News
- Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare ConferenceBusiness Wire
- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Ironwood Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]Seeking Alpha
- Ironwood Pharmaceuticals Reports Third Quarter 2024 ResultsBusiness Wire
- Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]Yahoo! Finance
IRWD
Earnings
- 11/7/24 - Miss
IRWD
Sec Filings
- 11/20/24 - Form 4
- 11/20/24 - Form 4
- 11/15/24 - Form 144
- IRWD's page on the SEC website